At first sight, the business idea seems somehow strange: Who would deliberately choose to develop and produce pharmaceutical substances that are hardly required and if so, only in small quantities. Dr. Raphael Vogler and Dr. Peter Gockel, the founders and owners of Freiburg-based ChemCon GmbH, have done exactly that - and found an ideal niche for their company. Even the largest companies of the industry are benefiting from ChemCon’s know-how and commission the Freiburg entrepreneurs to produce very special substances – "orphan drugs".
Further information:Dr. Raphael VoglerPresident, CEOChemCon GmbHEngesserstr. 4b79108 FreiburgTel.: +49 (0)761/5597-0Fax: +49 (0)761/5597-449E-mail: email@example.com